Dr Stephen Brecker is Care Group Lead for Cardiology and Director of the Cardiac Catheterisation Laboratories.
His major interests currently are in the field of interventional cardiology, coronary angioplasty and stenting, percutaneous closure of defects of the interatrial septum and transcatheter aortic valve implantation.
He has undertaken various clinical trials and observational studies.
Dr Brecker graduated in Medicine at St Thomas’s Hospital Medical School, University of London in 1984. Subsequently he completed Senior House Officer posts in London, at the Hammersmith Hospital, St Thomas’s Hospital, the Brompton Hospital and the National Hospital for Nervous Diseases, Queen Square.
He completed Registrar training in Cardiology at St. Thomas’s Hospital and the London Chest Hospital before taking up a British Heart Foundation Junior Research Fellowship at the Royal Brompton Hospital. He spent time as a Visiting Fellow at Johns Hopkins Hospital, Baltimore and having undertaken Senior Registrar appointments at the Royal Brompton Hospital and the London Chest Hospital, he was appointed as Consultant Cardiologist at St George’s Hospital and Honorary Senior Lecturer at St. George’s, University of London in 1996.
Dr Brecker has been recognised with the following awards:
British Heart Foundation Junior Research Fellowship
Fellow of the Royal College of Physicians
Fellow of the European Society of Cardiology
Fellow of the American College of Cardiology
Member of the British Cardiac Society
Member of the British Cardiovascular Intervention Society
S Brecker, M Rothman. Clinical Guide to Primary Angioplasty. Informa UK Ltd. London, 2010
SJD Brecker. Percutaneous device closure of the atrial septum. Abingdon. Informa. 2006.
Sharma R, Gaze DC, Pellerin D, Mehta RL, Gregson H, Streather CP, Collinson PO, Brecker SJ. Raised plasma N-terminal pro-B-type natriuretic peptide concentrations predict mortality and cardiac disease in end-stage renal disease. Heart. 2006 Oct;92(10):1518-9.
Sharma R, Gaze DC, Pellerin D, Mehta RL, Gregson H, Streather CP, Collinson PO, Brecker SJ. Evaluation of ischaemia-modified albumin as a marker of myocardial ischaemia in end-stage renal disease. Clin Sci (Lond). 2007 Jul;113(1):25-32